New presentations from ODRC today!

Several interesting presentations so far at the EASD; an interesting Claude Bernard lecture given by Professor Stephen Kahn from University of Washington, summing up his more than 30 years of research studying the pathophysiology of type 2 diabetes. Please see the webcast for his very good lecture.

Some of the other highlights (of course omitting the most), are: Heavily debates on the role of SGLT-2 inhibitors in type 1 diabetes, the importance of type 2 diabetes in the paediatric population (not only small adults!), status for beta-cell replacement therapy, the importance of heart failure, renal failure and the combination of the two in diabetes, Imeglimin: a new principle for glucose lowering treatment, the many faces of bariatric surgery, new biomarkers for diabetic nephropathy, and many, many more. I recommend to log in and follow the webcasts. 

 On Wednesday several presentations from our research center created attention:

Sindre Lee

Skeletal muscle beta-oxidation, stearoyl-CoA desaturase 1 and insulin sensitivity in subjects with or without prediabetes after 12 weeks of intensive exercise training.

Anh Thi Tran

Potential over- and under-treatment in glycaemic management of type 2 diabetes in general practice in Norway.

Kåre Birkeland

Cardiorenal disease is the most common first CV manifestation in type 2 diabetes and associated with increased mortality: a large multinational observational study.

Kjersti Nøkleby

Patterns in general practitioners' performance of type 2 diabetes procedures and relations with patients' risk of cardiovascular disease